WallStSmart

CommScope Holding Company, Inc. (VISN)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

CommScope Holding Company, Inc. generates 646% more annual revenue ($1.93B vs $258.90M). VISN leads profitability with a 118.2% profit margin vs -15.5%. VISN earns a higher WallStSmart Score of 58/100 (C).

VISN

Buy

58

out of 100

Grade: C

Growth: 5.3Profit: 7.0Value: 4.0Quality: 5.0

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

VISNSignificantly Overvalued (-47.1%)

Margin of Safety

-47.1%

Fair Value

$13.03

Current Price

$12.79

$0.23 premium

UndervaluedFair: $13.03Overvalued
ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

VISN4 strengths · Avg: 9.0/10
Profit MarginProfitability
118.2%10/10

Keeps 118 of every $100 in revenue as profit

Revenue GrowthGrowth
50.6%10/10

Revenue surging 50.6% year-over-year

P/E RatioValuation
17.6x8/10

Attractively priced relative to earnings

Operating MarginProfitability
29.1%8/10

Strong operational efficiency at 29.1%

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

VISN3 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

PEG RatioValuation
2.942/10

Expensive relative to growth rate

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : VISN

The strongest argument for VISN centers on Profit Margin, Revenue Growth, P/E Ratio. Profitability is solid with margins at 118.2% and operating margin at 29.1%. Revenue growth of 50.6% demonstrates continued momentum.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : VISN

The primary concerns for VISN are EPS Growth, Return on Equity, PEG Ratio.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

VISN profiles as a growth stock while ZEPP is a hypergrowth play — different risk/reward profiles.

VISN carries more volatility with a beta of 2.38 — expect wider price swings.

VISN is growing revenue faster at 50.6% — sustainability is the question.

Monitor COMMUNICATION EQUIPMENT industry trends, competitive dynamics, and regulatory changes.

Bottom Line

VISN scores higher overall (58/100 vs 41/100), backed by strong 118.2% margins and 50.6% revenue growth. ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

CommScope Holding Company, Inc.

TECHNOLOGY · COMMUNICATION EQUIPMENT · USA

Gyroscope Therapeutics Holdings plc, a clinical-stage gene therapy company, develops gene therapy products to treat patients with eye diseases. The company is headquartered in Stevenage, the United Kingdom.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?